| 1 |
Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007;28:1709-1716.
DOI
ScienceOn
|
| 2 |
Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
DOI
|
| 3 |
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:e44-e122.
DOI
ScienceOn
|
| 4 |
Sardar P, Chatterjee S, Giri J, et al. Intervention strategies for multi-vessel disease in patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol 2015;179:225-227.
DOI
ScienceOn
|
| 5 |
Park H, Hong YJ, Rhew SH, et al. Effect of revascularization strategy in patients with acute myocardial infarction and renal insufficiency with multivessel disease. Korean J Intern Med 2015;30:177-190.
DOI
ScienceOn
|
| 6 |
Muller DW, Topol EJ, Ellis SG, Sigmon KN, Lee K, Califf RM. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction: Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J 1991;121(4 Pt 1):1042-1049.
DOI
ScienceOn
|
| 7 |
Zhang D, Song X, Lv S, et al. Culprit vessel only versus multivessel percutaneous coronary intervention in patients presenting with ST-segment elevation myocardial infarction and multivessel disease. PLoS One 2014;9:e92316.
DOI
ScienceOn
|
webmaster
